These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37460052)
1. Risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: Role of ADAR2 in AMPA GluA2 RNA editing. Habib MZ; Elnahas EM; Aboul-Ela YM; Ebeid MA; Tarek M; Sadek DR; Negm EA; Abdelhakam DA; Aboul-Fotouh S Eur J Pharmacol; 2023 Sep; 955():175916. PubMed ID: 37460052 [TBL] [Abstract][Full Text] [Related]
2. Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat Brains. Mishra A; Singla R; Kumar R; Sharma A; Joshi R; Sarma P; Kaur G; Prajapat M; Bhatia A; Medhi B ACS Chem Neurosci; 2022 Oct; 13(20):2942-2961. PubMed ID: 36166499 [TBL] [Abstract][Full Text] [Related]
3. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons. Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999 [TBL] [Abstract][Full Text] [Related]
5. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients. Yamashita T; Kwak S Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598 [TBL] [Abstract][Full Text] [Related]
6. A new strategy to increase RNA editing at the Q/R site of GluA2 AMPA receptor subunits by targeting alternative splicing patterns of ADAR2. Chaytow H; Sethw Hassan I; Akbar S; Popplewell L; Dickson G; Chen PE J Neurosci Methods; 2021 Dec; 364():109357. PubMed ID: 34536489 [TBL] [Abstract][Full Text] [Related]
7. Comparative effect of atorvastatin and risperidone on modulation of TLR4/NF-κB/NOX-2 in a rat model of valproic acid-induced autism. Farrag EAE; Askar MH; Abdallah Z; Mahmoud SM; Abdulhai EA; Abdelrazik E; Nashar EME; Alasiri FM; Alqahtani ANS; Eldesoqui M; Eldib AM; Magdy A Behav Brain Funct; 2024 Sep; 20(1):26. PubMed ID: 39350139 [TBL] [Abstract][Full Text] [Related]
8. RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2. Yamashita T; Tadami C; Nishimoto Y; Hideyama T; Kimura D; Suzuki T; Kwak S Neurosci Res; 2012 May; 73(1):42-8. PubMed ID: 22366356 [TBL] [Abstract][Full Text] [Related]
9. Wu HF; Chen PS; Hsu YT; Lee CW; Wang TF; Chen YJ; Lin HC Mol Neurobiol; 2018 Jun; 55(6):4811-4824. PubMed ID: 28733898 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the RNA editing enzyme ADAR2 contributes to RGC death in a mouse model of glaucoma. Wang AL; Carroll RC; Nawy S PLoS One; 2014; 9(3):e91288. PubMed ID: 24608178 [TBL] [Abstract][Full Text] [Related]
11. Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease. Gaisler-Salomon I; Kravitz E; Feiler Y; Safran M; Biegon A; Amariglio N; Rechavi G Neurobiol Aging; 2014 Aug; 35(8):1785-91. PubMed ID: 24679603 [TBL] [Abstract][Full Text] [Related]
12. Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons. Bonini D; Filippini A; La Via L; Fiorentini C; Fumagalli F; Colombi M; Barbon A RNA Biol; 2015; 12(1):43-53. PubMed ID: 25625181 [TBL] [Abstract][Full Text] [Related]
13. Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism. Wu HF; Lu TY; Chu MC; Chen PS; Lee CW; Lin HC Neuropharmacology; 2020 Jan; 162():107736. PubMed ID: 31398381 [TBL] [Abstract][Full Text] [Related]
14. A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia. Kubota-Sakashita M; Iwamoto K; Bundo M; Kato T Mol Brain; 2014 Jan; 7():5. PubMed ID: 24443933 [TBL] [Abstract][Full Text] [Related]
15. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma. Oakes E; Anderson A; Cohen-Gadol A; Hundley HA J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531 [TBL] [Abstract][Full Text] [Related]
16. RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases. Hosaka T; Tsuji H; Kwak S Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681616 [TBL] [Abstract][Full Text] [Related]
17. Zebrafish Adar2 Edits the Q/R site of AMPA receptor Subunit gria2α transcript to ensure normal development of nervous system and cranial neural crest cells. Li IC; Chen YC; Wang YY; Tzeng BW; Ou CW; Lau YY; Wu KM; Chan TM; Lin WH; Hwang SP; Chow WY PLoS One; 2014; 9(5):e97133. PubMed ID: 24818983 [TBL] [Abstract][Full Text] [Related]
18. Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice. Hara Y; Ago Y; Taruta A; Hasebe S; Kawase H; Tanabe W; Tsukada S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K Psychopharmacology (Berl); 2017 Nov; 234(21):3217-3228. PubMed ID: 28798977 [TBL] [Abstract][Full Text] [Related]
19. Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination. Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GAM; Aboul-Fotouh S Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jun; 116():110522. PubMed ID: 35131336 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats. Abhishek M; Rubal S; Rohit K; Rupa J; Phulen S; Gurjeet K; Raj SA; Manisha P; Alka B; Ramprasad P; Bikash M J Ethnopharmacol; 2022 Jul; 293():115199. PubMed ID: 35346813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]